Acceder
  1. Inicio
  2. Perfil de Billod
  3. Contenidos recomendados por Billod

Contenidos recomendados por Billod

Billod 22/12/17 10:35
Ha respondido al tema Chicharros USA - bolsa internacional
Enhorabuena a los que habéis pillado el jornalero de las cryptos. Ami me ha pillado dentro. No me inquieta mucho, estamos en zona de dolor. Estamos acostumbrados a las farmas ;)
Ir a respuesta
Billod 18/12/17 12:42
Ha respondido al tema Chicharros USA - bolsa internacional
en epoca de guerra todo agujero es trinchera. Salen hasta de debajo de las piedras, como cuando la época de las Marijuanis Esto me recuerda a Terra... estamos en la primera fase (y recordad, aunque toque los 158, hay que vender algún dia)
Ir a respuesta
Billod 13/12/17 16:39
Ha respondido al tema Chicharros USA - bolsa internacional
IMUC, las llevo a 2,5 $ compradas en julio, jejejje a ver si recupero ;)   https://www.streetinsider.com/dr/news.php?id=13598278   ImmunoCellular Therapeutics (IMUC) Says it Achieved Key Milestone in Stem-to-T-Cell Research Immuno-Oncology Program December 13, 2017 4:19 PM ImmunoCellular Therapeutics, Ltd. ((NYSE: IMUC) announced today that it has achieved a key milestone in its research-stage Stem-to-T-Cell immuno-oncology program. The milestone represents an important step toward stimulating the patient's immune system to produce an unlimited supply of killer T cells that specifically target and destroy tumor cells with minimal side effects. This approach could be effective in treating many types of cancers. The research team at ImmunoCellular successfully packaged a T cell receptor (TCR) DNA sequence into a lentiviral vector, which was then used to transfect human hematopoietic stem cells. The Company has been able to verify successful transfer of genetic material into the stem cells, and plans to continue to work toward optimizing the transfection process. The Company believes that this completed phase of the Stem-to-T-Cell development is an important component of the proof-of-concept work for this technology, and represents a critical step in advancing toward preclinical testing. "We are excited to have achieved this critical initial milestone in our Stem-to-T-Cell program, and to have generated a body of scientific evidence of successful transfection and proof that the transfected human hematopoietic stem cells bearing the TCR were able to grow robustly for several generations," said Steven J. Swanson, PhD, Senior Vice President, Research. "We and our collaborators are on schedule to undertake next anticipated steps designed to enhance the transfection process and advance toward preclinical testing. We remain committed to our vision to develop solutions for intractable cancers, extending the lives of cancer patients, and providing hope for a potential cure. We believe that our Stem-to-T-Cell program is potentially a game-changing treatment for cancer." Anthony J. Gringeri, PhD, President and Chief Executive Officer commented: "We are proud of the achievements of our research team and the important scientific validation of our Stem-to-T-Cell program generated to date. We believe that our stem cell technology represents a major step forward in immuno-oncology, and has the potential for meaningful advantages over other novel immuno-oncology technologies, including use in combination approaches. With our strengthened financial condition and cash reserves, we intend to continue to focus our resources on achieving additional research milestones over the next 18 months. We are also continuing to explore potential collaborations for our clinical programs and other strategic alternatives for our Company."
Ir a respuesta
Billod 13/12/17 16:08
Ha respondido al tema Chicharros USA - bolsa internacional
DPW Este comentario de IHUB me parece acertado. Es de uno de los traders mas activos Ojo, manteniendo la cautela, y como dicen los toreros, "no hay que perder la cara al toro..." https://investorshub.advfn.com/boards/read_msg.aspx?message_id=136872789 DPW close $5.05. I agree and I would hate to be out when we see another over $2.00 move up like we saw yesterday and today from lows to highs. That should easily put us over $7.00 but when you consider the percentage gains we have seen in the last week DPW saw over 100% gains refer to the charts. The swings last week were insane but after todays news in the days ahead we should see the float get bought up by more serious investor's and lose a lot of the flip traders as we leave them behind us in the dust. Tomorrow let's go for the $6.00 break. I hope people saw that earlier today the entire DPW float had churned almost twice at about $4.45 per share average until we had that 1 large market sell order hit and then invite a lot of flip traders. Hopefully tomorrow we can trade a lot cleaner on the way up ahead. 
Ir a respuesta
Billod 13/12/17 15:21
Ha respondido al tema Chicharros USA - bolsa internacional
DPW, tranquilo, dale unos dias .... yo las llevo a 4,20 de media y con ellas compradas llegaron a tocar el 2,30 el viernes Me las voy a plantear a medio plazo (si todo va bien).
Ir a respuesta